Insights

As a leader in multiplex diagnostics at the Point of Need, QuantuMDx is committed to sharing ideas and being actively engaged to turn challenges into opportunities. Access here our news, blogs and events.

News

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 10 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its SARS-CoV-2 RT -PCR detection assay, has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…
Read More
News

Martin Walton appointed as Chief Financial Officer

NEWCASTLE UPON TYNE, UK, 24 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce…
Read More
News

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its…
Read More
News SARS-CoV-2 virus

QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529

NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open PCR platforms and its rapid PCR device, Q-POC™, as well as its future respiratory panel (SARS-CoV-2, Flu A, Flu B…
Read More